Radiopharmaceuticals Revolutionize Cancer Treatment

Ken Song, former CEO of a small biotech, initially avoided oncology due to its crowded nature. However, after receiving inquiries from investors about the possibility of developing more effective and widely applicable cancer treatments using radiopharmaceuticals, which deliver targeted radiation to cancer cells, he became interested in the field.